Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

  • Author: Kristine Patterson, MD (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/5/18 (What's New)

Summary

  • IV zidovudine near delivery is recommended for HIV-infected pregnant women with HIV-1 RNA > 1000 copies/mL or unknown HIV-1 RNA levels unless there is evidence of resistance or toxicity (Management Guidelines)[DHHS Perinatal]
  • Neonatal zidovudine prophylaxis is also recommended for:[DHHS Perinatal]
    • 4 weeks for full-term infants whose mother received suppressive ART regimen during pregnancy
  • Mode of Delivery
      Concurrent Antiretroviral Therapy and Other Medications

      Action required